The Ensign Group, Inc.
ENSG · Price history
Price at last available close
$184.11
+$7.75 (+4.39%) 1M
2026-10-28
Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.
Company & revenue
About The Ensign Group, Inc.
Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.
Who they are
The Ensign Group, Inc. operates as a healthcare provider, primarily concentrating on post-acute care services, alongside other supporting business ventures. The company's activities are organized into two main divisions: Skilled Services and Real Estate. Within its Skilled Services segment, Ensign provides extensive short-term and long-term nursing care tailored for patients recovering from extended illnesses, managing chronic health conditions, or requiring elder care.
How they make money
The Ensign Group operates as a holding company whose independent subsidiaries provide post-acute healthcare services, including skilled nursing, senior living, and rehabilitative care. Revenue is primarily generated through reimbursement from government programs like Medicare and Medicaid, as well as private pay sources for senior living and ancillary services.
Products & services
Skilled nursing, senior living, rehabilitative services, mobile diagnostics, and medical transportation.
Brands & revenue mix
No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.
Product / operating segments
Geographic revenue
No reconciled geographic revenue breakdown was confirmed for the current research period.
Customer concentration
The company is highly dependent on government reimbursement programs, specifically Medicare and Medicaid, which constitute a significant portion of its revenue.
Suppliers, materials & equipment
- Medical supply and pharmaceutical distributors — The company relies on various third-party vendors for medical supplies, pharmaceuticals, and therapy services; specific supplier names are not disclosed.Source
Wall Street Score
Overall investment score · Quality, value, risk and opportunity
51
Fair
View category scores →
Company Quality
How good is the actual business—regardless of today’s stock price?
64
Fair
Financial Strength
38
Business Quality / Moat
95
Management
55
Growth Quality
54
Risk / Durability
95
Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.
Opportunity
Opportunity Score · How does the current price compare with estimated value?
64
Fully Valued
Based on current valuation, company quality, recent trends, and available market signals.
View score details →
Model Outlook
12-month model · What does the model think happens next?
65/100
Building Historical Record
Model Score 65/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.
Probability unavailable — the model has not produced a calibrated probability yet.
Click for full breakdown →
WSS View
The quick read
The overall Wall Street Score is mixed across its combined quality, valuation and risk inputs. Review the category scores to identify what is helping or hurting the result.
At today’s price, the WSS valuation framework currently reads as moderate rather than unusually attractive.
The model outlook is currently moderate.
- •Valuation scores attractively
- •Recent buyback activity is present
- •Revenue fundamentals are weak
- •Debt / balance-sheet profile needs attention
Company-specific research
Questions worth answering for ENSG
These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.
- •Can ENSG maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
- •Is ENSG's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
- •Is ENSG's debt load manageable relative to cash generation, interest costs and upcoming maturities?
- •Is ENSG's valuation discount tied to a temporary concern or to a longer-term business risk?
Essential Investment Snapshot
Wall Street Score
51
Opportunity Score
64
Market Cap
$10.73B
P/E Ratio
26.2
EPS
$6.57
52-Week High
$218.00
52-Week Low
$141.58
Beta
0.69
Intrinsic Value
$252.95
Analyst Target
$215.00
Shares Outstanding
58.9M
Total Revenue
$5.49B
Total Debt
$2.25B
Dividend Yield (TTM)
0.14%
Liquidation Value / Share
$41.54
Dividend / Share (TTM)
$0.26
Momentum & Volatility Signals
Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.
Building upward momentum
Normal movement
A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.
A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.
Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.
Notices for ENSG
Detected from reported data — verify before acting.Dividend history reported
Dividend payments are recorded. Review the dates and regular/special classification below; past payments do not guarantee future dividends.
Historical repurchase activity
Reported cash flows or share-count measures indicate past repurchase activity. This does not verify an active buyback authorization or future purchases.
Community Sentiment
0 active · 0 total callsNo personal call yet on ENSG.
Potential upside factors
- +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
- +Decentralized operating model.
- +Strong acquisition and integration capabilities.
- +Positive free cash flow may provide capacity to invest in growth.
Potential downside factors
- −Key risks may include competition, margin pressure, debt levels, valuation risk, and changes in demand within the Medical - Care Facilities industry.
- −Government reimbursement rate changes.
- −Labor shortages and rising wage costs.
- −Regulatory compliance and litigation risks.
These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.
Create a free account to make a call.
Scores
Click any score for full breakdownWas this stock page easy to understand?
One click helps us improve the research experience. This is not tied to an investment decision.
Score Changes
6 historical score records availablePrevious Score
50
Sep 21, 2026
Change
+0.3
points
Current Score
51
Oct 1, 2026
Category Changes
ENSG increased 0.3 points because overall fundamentals improved.
Projected Score
Projected Score
54
Projected Change
+3.0 points
Preliminary comparable-period financial changes suggest improvement of approximately 3.0 points. This is a projected estimate, not the official WallStreetScore.
Price vs. Value
UndervaluedCurrent Price
$184.11
Model Intrinsic Value
$252.95
Difference
−$68.84
-27.2% vs IV
Margin of Safety
27.2%
Financial Charts
Revenue
Additional Metrics
Operating Cash Flow
Total Debt
Total Assets
Net Margin %
Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.
| Line Item | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.49B | $5.06B | $4.26B | $3.73B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Cost of Revenue | $4.71B | $4.26B | $3.59B | $3.14B | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Gross Profit | $775.9M | $799.5M | $667.6M | $590.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Research & Development | $0.00 | $0.00 | $0.00 | $0.00 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| SG&A Expenses | $298.3M | $269.8M | $225.1M | $263.0M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Expenses | $308.5M | $374.1M | $309.3M | $335.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| EBITDA | $621.3M | $567.9M | $478.5M | $353.2M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Operating Income | $467.4M | $425.3M | $358.3M | $255.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Interest Expense | $7.8M | $8.0M | $8.3M | $8.1M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Before Tax | $498.9M | $455.6M | $386.1M | $272.8M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Income Tax Expense | $119.9M | $111.4M | $87.6M | $62.9M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Net Income | $378.7M | $344.0M | $298.0M | $209.4M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic EPS | $6.57 | $6.00 | $5.26 | $3.76 | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Basic Shares | 57.96M | 57.31M | 56.66M | 55.71M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
| Diluted Shares | 59.48M | 58.87M | 58.24M | 57.32M | ···· | ···· | ···· | ···· | ···· | ···· | ···· |
Earnings Summary
Revenue
$1.44B
Estimate unavailable.
Revenue Beat/Miss
Not available (no estimate stored)
EPS
$1.68
Estimate unavailable.
EPS Beat/Miss
Not available (no estimate stored)
Debt Change
+10.3%
Cash Change
-27.9%
Margin Change
+0.1 pp
Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.
Financial Changes Since Prior Period
What Improved
- Margins expanded
What Weakened
- Cash position declined
- Debt increased
Potential Score Impact
Positive indicators included revenue growth, EPS growth, net income margin. Pressure indicators included cash levels, debt levels. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.
Stored Earnings Analysis
Revenue increased 17.3%. EPS increased 16.7%. Cash declined 27.9%. Total debt increased 10.3%. Net income margin improved by 0.1 percentage points.
Earnings-Call Transcript
Earnings-call transcript analysis is not currently available.
These results may influence future scores when the next evaluation is completed.
Insider Activity
Guru / Smart Money
Guru Score
Smart Money
Number of Gurus
Total Guru Value
Avg Portfolio Weight
Largest Holder
Largest Holder %
New Positions
Increased Positions
Reduced Positions
Exited Positions
Net Guru Sentiment
Short Interest
Dividend History
Log in to view dividend history.
Conservative Projected Values
3 Years
$———.——
5 Years
$———.——
10 Years
$———.——
Conservative Projection Rate
——%
Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.
Conservative Projected Values
Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.
Start 7-Day Free TrialHistorical Outperformance Record
Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.
Start 7-Day Free TrialHistorical Trends
6 historical recordsHistorical Score Chart
3 of 6 records shownWall Street Score
Debt Score
Revenue Score
Asset Score
Capital Score
Management Score
Moat Score
Valuation Score
Buffett Score
Intrinsic Value
Value Reference
Margin of Safety %
Related Companies
Medical - Care FacilitiesNews
Why Ensign Group (ENSG) is a Top Value Stock for the Long-Term
ENSG INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds The Ensign Group (ENSG) Investors of Securities Class Action Lawsuit Deadline on December 7, 2026
Bronstein, Gewirtz & Grossman LLC Urges The Ensign Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
ROSEN, THE FIRST FILING FIRM, Encourages The Ensign Group, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - ENSG
Rumor Mill · ENSG
Corporate developments & opportunities
No reviewed developments match this filter.
Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.
Related Stock Research
Continue researching this company with related Wall Street Score rankings and investing guides.
Score Alerts
Premium unlocks alerts when a score rises, falls, or reaches your target price.
Start 7-Day Free TrialPortfolio Score
Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.
Start 7-Day Free Trial